Wladimir Hogenhuis

Wladimir Hogenhuis

Director/Board Member at REZOLUTE, INC.

Net worth: 472 716 $ as of 31/10/2026

62 year
Health Technology
Consumer Services

Profile

Dr. Wladimir Hogenhuis is a President, Chief Executive Officer & Director at Driver Bioengineering, Inc. and an Independent Director at Rezolute, Inc. He is on the Board of Directors at Driver Bioengineering, Inc., Rezolute, Inc., GATT Technologies BV and IHP Therapeutics, Inc. Dr. Hogenhuis was previously employed as a Chief Operating Officer by Ultragenyx Pharmaceutical, Inc., a Senior Vice President by GlaxoSmithKline Plc, and a General Manager-Neuroscience by Merck & Co., Inc. He also served on the board at Vision 2020.
He received his MBA from The Wharton School of the University of Pennsylvania and a doctorate degree from the University of Leiden.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/10/2026 119,675 ( 0.12% ) 472 716 $ 31/10/2026

Wladimir Hogenhuis active positions

CompaniesPositionStart
REZOLUTE, INC. Director/Board Member 02/03/2021
Chief Executive Officer 28/04/2022
Director/Board Member 01/05/2020
IHP Therapeutics, Inc.
Director/Board Member -

Former positions of Wladimir Hogenhuis

CompaniesPositionEnd
ULTRAGENYX PHARMACEUTICAL INC. Chief Operating Officer 10/01/2020
GSK PLC Corporate Officer/Principal 01/09/2018
MERCK & CO., INC. Corporate Officer/Principal -
Vision 2020
Director/Board Member -
See the detail of Wladimir Hogenhuis's experience

Education of Wladimir Hogenhuis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Consumer Services

Vision 2020

Health Technology

Health Technology

Consumer Services

Health Technology

IHP Therapeutics, Inc.

  1. Stock Market
  2. Insiders
  3. Wladimir Hogenhuis